Author:
Lee Kyeonmin,Lee Yun Yeong,Suh Mina,Jun Jae Kwan,Park Bomi,Kim Yeol,Choi Kui Son
Abstract
AbstractThe coronavirus disease (COVID-19) pandemic significantly declined cancer screening rates worldwide. Its impact on the South Korean population is unclear, depending on socioeconomic status (SES), residence, and history of chronic disease. This study utilized data (2018–2020) from the Korean National Cancer Screening Survey, an annual cross-sectional study employing nationally representative random sampling. Cancer screening rates were defined as the proportion of the eligible population who received respective cancer screening within the last 1 year and investigated four major cancers (stomach, colorectal, breast, and cervical). Screening rates every year were compared with screening rate ratios (SRRs) and the corresponding 95% confidence intervals (CIs). Between 2019 and 2020, screening rates declined significantly by 23%, 17%, 12%, and 8% for colorectal cancer (SRR 0.77; 95% CI 0.73–0.82), stomach cancer (SRR 0.83; 95% CI 0.79–0.87), breast cancer (SRR 0.88; 95% CI 0.82–0.93), and cervical cancer (SRR 0.92; 95% CI 0.87–0.97), respectively. Regardless of cancer type, screening was significantly lower in metropolitan residents, those with higher SES, and, interestingly, those without a history of chronic diseases. The significant decline in cancer screening during the pandemic requires urgent political intervention to reduce the burden of future cancer incidence and mortality.
Funder
The Grant-in-Aid for Cancer Research and Control of the National Cancer Center, Korea
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19, https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19--22-april-2020 (2020).
2. Loud, J. T. & Murphy, J. Cancer Screening and early detection in the 21(st) century. Semin. Oncol. Nurs. 33, 121–128. https://doi.org/10.1016/j.soncn.2017.02.002 (2017).
3. Walker, M. J. et al. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Prev Med 151, 106586. https://doi.org/10.1016/j.ypmed.2021.106586 (2021).
4. Tsai, H. Y. et al. Effects of the COVID-19 pandemic on breast cancer screening in Taiwan. Breast 54, 52–55. https://doi.org/10.1016/j.breast.2020.08.014 (2020).
5. Cheng, S. Y. et al. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy. J. Gastroenterol. Hepatol. 36, 1614–1619. https://doi.org/10.1111/jgh.15325 (2021).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献